Kardium
Focus: Kardium is a medical device company specializing in globe mapping and ablation systems for diagnosing and treating atrial fibrillation. Founded in 2007 and headquartered in Burnaby, BC, the company operates in the cardiovascular device space with a focused product portfolio.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Kardium
AI assessmentNot HiringNo open roles listed right now. Follow Kardium to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
8 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Globe Mapping and Ablation System
Growing
Growth
Core commercial platform with established clinical evidence supporting broader adoption in AF management.
Globe Pulsed Field System
Help build intelligence for Kardium
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.